Marketresearchnews

Tuesday, 28 July 2020

Wound Closure Device Market 2020 Global Trend, Segmentation And Opportunities, Forecast 2023

Overview:

Wound closure device holds the edges of wound together firmly to facilitate speedy wound healing. The global wound closure devices market is expected to strike a CAGR of 6.9% over the forecast period of 2018-2023, asserts Market Research Future (MRFR) in an in-depth study.

The steep rise in the volume of surgical procedures owing to surging cases of road accidents, sports injuries, burns, and other surgical procedures have subsequently generated high demand for wound closure devices and boosted the growth of the global wound closure device market.

An increase in global geriatric population has further augmented the growth of the global wound closure device market. The aged populace undergoes a substantially high number of surgeries and also their self-wound healing capacity is reduced owing to old age which induces high demand for wound closure devices. In addition, the widespread prevalence of diabetes across the globe has reflected positively on the growth of the global wound closure devices market. Wound healing in diabetic patients is impaired and they require wound closure devices for effective healing. In addition, foot ulcers are very common among diabetic patients which require wound closure devices and consequently boost the market for wound closure devices.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/2001

Advancement in wound closure technology has resulted in the development of improved wound closure devices which are improved and without the drawbacks of conventional wound closure devices. Other factors substantiating the growth of the market include augmenting need for reducing surgical expenditure and need to reduce hospital stay.

On the other hand, unfavorable reimbursement scenario might restrain the growth of the global wound closure devices market to some extent. Additionally, risks of infection, discomfort & pain caused by traditional wound closure devices, and scarring associated with wound closure devices are also possible bottlenecks to the growth of the market.

Segmentation

The global wound closure device market has been segmented based on device, application, and end user.

By device, the global wound closure market has been segmented into adhesives, staples, sutures, and mechanical wound closure devices. The adhesives segment has been further segmented into fibrin tissue adhesives and cyanoacrylates. The sutures segment has been further segmented into absorbable, non- absorbable, braided, and monofilament.

By application, the global wound closure device market has been segmented into burns, ulcers, surgical wounds, pressure ulcers, diabetic ulcers, and arterial ulcers. The surgical wounds segment has been further segmented into chronic wounds, acute wounds, and others.

By end user, the global wound closure device market has been segmented into hospitals, community healthcare service providers, ambulatory surgical centers, and home care.

Regional Analysis

The Americas, Asia Pacific (APAC), Europe, and the Middle East & Africa (MEA) are the key markets for wound closure device.

The Americas account for the majority share of the global wound closure device market. Rise in a number of surgical procedure, increasing incidences of road accidents, sports injuries and orthopedic surgeries in the region spur demand for wound closure devices. As per the American Association for the Surgery of Trauma, approximately over 150,000 deaths due to injuries and over 3 million non-fatal injuries are reported in the US every year. Well spread awareness regarding wound closure technology and high healthcare spending are other factors.

Europe is the second largest market for wound closure device. Increase in the occurrence of sports injuries and accidents, as well as rise in number of surgical procedures due to growing aging population, are factors driving Europe wound closure device market.

APAC is poised to be the fastest growing market for wound closure device. A key factor influencing the growth of the market is the widespread prevalence of chronic diseases in the region, especially diabetes which results in delayed wound healing and in turn, boosts the market for wound closure device. Diabetic foot ulcers are very common in APAC. Increased healthcare spending and increasing awareness regarding wound closure devices have further driven the market.

The MEA market accounts for the minority share of the global wound closure device market. Underdeveloped healthcare sector, poor medical facilities, and low healthcare spending are factors that limit market growth.

Competitive Landscape

The eminent players in the global wound closure device market include 3M, DACH Medical Group, Smith & Nephew, Ethicon Inc., Gecko Biomedical, Integra LifeScience, Baxter International, Arthrex GmbH, ConvaTec, B. Braun Melsungen AG, BSN medical Inc., Kinetic Concepts, Abbott Laboratories, CP Medical, Derma Sciences, and Medtronic.

Industry Updates

In February 2019, Teleflex, a provider of specialty medical devices, announced that it has received FDA premarket approval for its wound closure Manta device designed to seal femoral punctures following vascular access medical procedures. The company plans to launch the manta device in the US in 2019 to ensure strong initial outcomes.
In November 2018, BandGrip, Inc., a medical device company focused on revolutionizing wound closure, introduced a new wound closure device BandGrip Micro-Anchor Skin Closures which represents a significant innovation in wound care. The new wound closure device uses micro-anchor technology for enhanced healing results. The new device is non-invasive, quick, and equipped with micro-anchors which facilitate firm grip to hold wound edges together.

Browse Complete Report Details @ https://www.marketresearchfuture.com/reports/wound-closure-device-market-2001

Pituitary Cancer Market Growth Analysis, Industry Trends, And Forecast By 2023

Market Scenario

Pituitary Cancer Market is expected to register significant growth over the forecast period. The market is projected to register a 5.7% CAGR over the forecast period. Pituitary cancers occur in the pituitary gland that is located beyond the nose. Factors such as the rising prevalence of pituitary cancer are expected to drive market growth. Moreover, the increasing research and development expenditure in the field of oncology for the development of innovative drugs to treat cancer is also expected to boost the market growth.

However, the side effects of the treatment and stringent government regulations are expected to hamper the market growth.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1657

Segmentation

The Global Pituitary Cancer Market has been segmented into Cancer Type, Treatment Type, End User, and Region.

Based on cancer type, the global pituitary cancer market has been segmented into adrenocorticotropic hormone-secreting (ACTH) tumor, growth hormone-secreting tumor, prolactin-secreting tumor, and thyroid-stimulating hormone-secreting tumor.

The global pituitary cancer market, by treatment type, has been segmented into chemotherapy, surgery, radiation therapy, and others. The surgery segment is further segmented into endoscopic trans nasal transsphenoidal surgery and craniotomy. The radiation therapy segment is further segmented into stereotactic radiosurgery, external beam radiation, intensity-modulated radiation therapy (IMRT), and proton beam therapy.

The global pituitary cancer market, by end user, has been segmented into hospitals & clinics, specialty clinics, and others.

The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The pituitary cancer market in the Americas has further been segmented into North America and Latin America, with the North American market divided into the US and Canada.

The European pituitary cancer market has been segmented into Western Europe and Eastern Europe. The market in Western Europe has further been classified as France, Germany, Spain, the UK, Italy, and the rest of Western Europe.

The pituitary cancer market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific.

The Middle East & Africa pituitary cancer market has been segmented into the Middle East and Africa.

Key Players

Amgen Inc. (US), Bristol-Myers Squibb Company (US), Celgene Corporation (US), Eli Lilly and Company (US), Astellas Pharma Inc. (Japan), Merck & Co., Inc. (US), Novartis AG (Switzerland), Pfizer Inc. (US), AstraZeneca (UK), Mylan N.V. (US), Johnson & Johnson Services, Inc. (US), Onxeo (France), Ipsen Pharmaceuticals (France), Salix Pharmaceuticals, Inc. (US), and Strides Pharma Science Limited (India) are some of the key players operating in the global pituitary cancer market.

Regional Market Summary

Geographically, the market has been segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is expected to dominate the global pituitary cancer market owing to the rising prevalence of pituitary cancer and presence of major market players in the region, such as Amgen Inc., Bristol-Myers Squibb Company, Celgene Corporation, Eli Lilly and Company, Merck & Co., Inc., and Pfizer Inc.

Europe is expected to hold the second-largest share of the pituitary cancer market owing to the presence of major market players such as AstraZeneca, Novartis AG, GlaxoSmithKline plc, Onex, and Ipsen Pharmaceuticals, among others. Moreover, rising R&D activities for the development of advanced treatment options for pituitary cancer is also expected to drive the market growth.

Asia-Pacific is expected to be the fastest-growing regional market owing to the increasing awareness regarding various types of cancer, including pituitary cancer, growing incidence rate of Pituitary cancer and increasing R&D in the field of oncology.

The pituitary cancer market in the Middle East & Africa is expected to register slow growth during the forecast period owing to the lack of awareness regarding cancer.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/pituitary-cancer-market-1657

Top Trends In Stroke Disorder & Treatment Market 2020 – 2023 By Growth Factors And Industry Players Overview

Heart problems and brain problems are considered among most dangerous medical problems, and their treatments are considered to be most expensive. Heart strokes and brain strokes can strike any moment and can be fatal. Hence, the market offering treatment for it is always lucrative. Globally it is increasing rapidly. The major factor that drives the growth of this market is the increasing high blood pressure patients. Due to increasing alcoholism and patients with diabetes, cardiovascular diseases are increasing the growth of this disorder and the market offering its treatment.

Market Research Future (MRFR) has published a research report about the global stroke disorder and treatment market that estimates huge aggrandizement in this market between 2016 and 2022. This report provides a detailed analysis of the market structure along with a forecast for the next seven years. It analyzes the market on the basis of various factors including porters five force analysis, price analysis, and supply chain analysis. Providing insights about the current market size and future prospects, this report features expert opinions. Profiling the key players in the market, this report covers competitive developments such as joint ventures, mergers and acquisitions, new product developments, strategic alliances, and research and developments in the global market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1651

The global stroke disorder and treatment market has been segmented into medicines, treatment, types, and lastly region. On the basis of medicines, this market has been segmented into anticoagulants, anti-hypertensive, and antiplatelet. Anticoagulants, also called blood thinners, are chemical substances that prevent or reduce coagulation of blood, prolonging the clotting time. Apixaban (Eliquis), dabigatran (Pradaxa), edoxaban (Savaysa), enoxaparin (Lovenox), fondaparinux (Arixtra), heparin, rivaroxaban (Xarelto), and warfarin (Coumadin) are some examples of anticoagulants. Antiplatelet is a member of a class of pharmaceutical drugs that decrease platelet aggregation and inhibit thrombus formation. They are more effective in the arterial circulation compared anticoagulants. Examples of antiplatelet include clopidogrel (Plavix), dipyridamole/aspirin (Aggrenox), eptifibatide (Integrilin), prasugrel (Effient), ticagrelor (Brilinta), and ticlodipine (Ticlid). Antihypertensives are a class of drugs that are used to treat hypertension (high blood pressure). Examples of antihypertensives include benazepril (Lotensin), captopril (Capoten), enalapril (Vasotec), lisinopril (Zestril and Prinivil), perindopril (Aceon), quinapril (Accupril), ramipril (Altace), and trandolapril (Mavik).

Treatment-based segmentation of the market covers tissue plasminogen activator (TPA) and endovascular procedures. TPA is an enzyme involved in the breakdown of blood clots and dissolves them. The endovascular procedure is surgery. Being innovative, it is a less invasive procedure, popularly used for treating problems affecting the blood vessels, such as an aneurysm, which is a swelling or “ballooning” of the blood vessel. By types, the market has been segmented into hemorrhagic strokes and ischemic stroke. The weakened blood vessel leakage is called a hemorrhagic stroke. Its two categories are aneurysms and arteriovenous malformations. Ischemic strokes occur as a result of an obstruction within a blood vessel supplying blood to the brain.

The regional segmentation of global stroke disorder and treatment market cover North America, Europe, and the Asia Pacific. The key players of this market are primarily based in these continents. In other parts of the world, the market for stroke disorder and treatment is limited due to less advanced medical facilities, little investment in health care, lack of awareness about stroke disorder, and poor infrastructure. In North America and Europe, investments in research and development (R & D) and advanced medical facilities boost this market. According to this report, the market in North America is expected to rise and earn maximum revenue by the end of the forecast period. Europe is the second largest market. The Asia Pacific is expected to be the fastest growing market for stroke disorder and treatment because some countries in this region do have advanced medical facilities.

Key Players

The key players of global stroke disorder and treatment market include AstraZeneca {United Kingdom (UK)}, Bayer Pharma AG (Germany), Daiichi Sankyo (Japan), Novartis AG (Switzerland), and Pfizer {United States of America (US)}.

Latest Industry News

The US Food & Drug Administration (FDA) has approved the use of the Trevo clot retrieval device for up to 24 hours after symptom onset in certain patients presenting with acute ischemic stroke. The device has been indicated as initial therapy for ischemic stroke when used in conjunction with tissue plasminogen activator (TPA). Earlier, the use of this device was approved for use within 6 hours of symptom onset. 15 FEB 2018
BrainQ, an Israel-based startup aims to help stroke victims and those with spinal cord injuries treat their injuries. Their plan to achieve their goal is by offering personalized electromagnetic treatment protocol. They have raised the US $ 5.3 mn for the same. The general idea behind BrainQ is to use the patient’s brainwaves to generate a tailored treatment protocol. 15 MAY 2018.

Access Report @ https://www.marketresearchfuture.com/reports/stroke-disorder-treatment-market-1651

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Cerebral Vasospasm Market 2020 Global Trend, Segmentation And Opportunities, Forecast 2023

Global Cerebral Vasospasm Market Research Report, by Diagnosis (Computed Tomography Angiography, Digital Subtraction Angiography), Treatment (Nimodipine, Triple-H Therapy, Balloon Angioplasty), End-User (Hospitals, Clinics)– Global Forecast Till 2023

Global Cerebral Vasospasm Market - Scenario

The advances in medical knowledge are leading to the breakthroughs being achieved in the treatment of cerebral vasospasm. Reports that examine the medical device industry has been presented by Market Research Future, which produces reports on industry verticals that evaluate the market development and opportunities. The market is expected to gain a CAGR of 5.4 % in the upcoming period.

Cerebral vasospasm is most commonly observed in patients who survive subarachnoid hemorrhage. The narrowing of cerebral arteries is termed as cerebral vasospasm. Narrowing of cerebral artery leads to cerebral ischemia and then death. Increasing prevalence of subarachnoid hemorrhage and a rise in the prevalence of traumatic brain injury is the key factor driving the growth of the market. According to the Centers for Disease Control and Prevention 2017, 30% of the total injury deaths are due to traumatic brain injury in the US. Other factors contributing to the growth of the market are increasing hypertension among the population, rising adoption of smoking, changing lifestyle, growing geriatric population, increasing prevalence of bleeding disorders, rising use of blood thinners and the introduction of technologically advanced treatments.

However, factors such as high cost associated with treatment, risks associated with drugs and medication and a shortage of skilled professionals are expected to hinder the market growth during the forecast period.

Segmentation

Global cerebral vasospasm treatment market is segmented on the basis of type of treatment which includes triple-H therapy, nimodipine and other. On the basis of route of administration the market is segmented into oral, intravenous and intra-arterial and on the basis of end user the market is again segmented into hospitals, clinics and others.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1418

Key Players

Headsense Medical Ltd (Israel),
Braun Melsungen AG (Germany),
Minnetronix, Inc (US),
Bristol-Myers Squibb Company (US),
Boehringer Ingelheim GmbH (Germany)
Lundbeck A/S (Denmark)

Regional Analysis

Geographically, North America has the largest market of cerebral vasospasm. North America cerebral vasospasm market is driven by robust research & development practices along with growing advancements in the field of neurology. Europe has the second largest market of cerebral vasospasm which is followed by Asia Pacific. In Middle East and Africa the market is least due to limited development in the healthcare sector.

The report of global cerebral vasospasm market by Market Research Future comprises of extensive primary research along with detail analysis of qualitative as well as quantitative aspects by various industry experts and key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of current market scenario which includes past and estimated future market size with respect to value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The report also gives a broad study of the market’s different segments and regions.

Access More Details of the Report @ https://www.marketresearchfuture.com/reports/cerebral-vasospasm-market-1418

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Global Ventilator-Associated Pneumonia Market 2020 Business Insights & Deep Analysis To 2023 By World’s Top 10 Key Players

Global Ventilator-Associated Pneumonia Market Research Report: Information by Diagnosis (Clinical, Radiological, Microbiological, and Others), End User (Hospitals & Clinics, Research & Academic Institutes, Ambulatory Care Centers, and Others), and Region (the Americas, Europe, Asia-Pacific, and the Middle East & Africa)—Forecast till 2025

Market Scenario

According to CDC in 2013, there were 2.8 million traumatic brain injury visits to emergency department and hospitals. The emergency department visits of brain injury patients increased by 47% from 2007. Thus, increasing incidence of TBI drives the growth of the market. Furthermore, increasing geriatric population is likely to fuel the market to grow. According to the U.S. Census Bureau in 2015, 47.8 million people were 65 years or older, and in 2060, 98.2 million are expected to be 65 years or older. Such increasing trend in the geriatric population provides favorable backgrounds for the market to grow.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1377

Ventilator-associated pneumonia is a type of lung infection caused to patients who are on ventilators. Ventilator-associated pneumonia is caused mainly due to lung disease, neurologic disease, and trauma to critically ill persons. Diagnosing VAP requires aggressive surveillance combined with the radiographic examination, bedside examination, and microbiologic examinations of respiratory secretions. Growing Intensive Care Unit Admissions due to rising prevalence of respiratory diseases, rising number of ICU beds and high incidence of traumatic injuries provides favorable backgrounds for the market to grow.

However, factors such as expensive diagnostic tests, high ventilator charges, inappropriate reimbursement scenario, risks associated with ventilators are expected to restrict the market growth during the forecast period.

Key players

Some of the key players contributing in the global Ventilator Associated Pneumonia (VAP) Therapeutics Market are Merck & Co., Inc. (U.S.), Adenium Biotech ApS (Denmark), AstraZeneca (UK), MedImmune (US), Nabriva Therapeutics AG (Austria) and other.

Segmentation

The global Ventilator-associated pneumonia market is segmented on the basis of diagnosis, mode of treatment, and end-user. The Ventilator-associated pneumonia market, by diagnosis categorized into Clinical Examination, Radiological Examination, Microbiological Analysis and others. Microbiological Analysis is further sub-segmented into Blood and pleural fluid cultures, Nonquantitative or semi-quantitative airway sampling and Quantitative cultures of airway specimens. Mode of treatment segment is segmented into Homecare, Hospital care, and others. On the basis of end-user, the market is segmented into Hospitals & Clinics, Research centers, Ambulatory Care Centers and Emergency Medical Services (EMS).

Regional Market Summary

The Ventilator-associated pneumonia market is dominated by North America owing to the rising geriatric population within the region. The U.S. Census Bureau projected that in 2060, 19.7 million would be of age 85 or older. This influences the growth of this market in this region.

Asia Pacific was projected to be the fastest growing region for the global Ventilator-associated pneumonia market in 2017. The rising geriatric population, increasing healthcare expenditure and growing respiratory disorders in Asia is expected to drive market growth in this region. According to The Asian Development Bank (ADB), the geriatric population in Asia is estimated to reach 923 million by 2050. Thus, this provides favorable backgrounds for the Ventilator-associated pneumonia market to grow.

It is estimated that Europe stood second in the global Ventilator-associated pneumonia market owing to increasing prevalence of lung diseases. According to European respiratory society, more than 50% of deaths are due to lung diseases. Thus, increasing prevalence of lung diseases in this region influences the growth of this market in this region.

The Middle East and Africa holds the least share in the global Ventilator-associated pneumonia market due to the presence of stringent government policies, poor economies, under-developed healthcare infrastructure and low penetration of healthcare services, especially within the African region.

Access More Details of the Report @ https://www.marketresearchfuture.com/reports/ventilator-associated-pneumonia-vap-market-1377

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Enema Bags Market 2020 Global Growth Insights, Trends, Size, Share And Forecast To 2023

Global Enema Bags Market Research Report: Information by Material Type (Silicone, Rubber, and Others), Indication (Constipation, Diarrhea, Obesity, Cancer, and Others), End User (Hospitals & Clinics, Research & Academic Institutes, and Others), and Region (the Americas, Europe, Asia-Pacific, and the Middle East & Africa)—Forecast till 2025

Market Scenario:

Some health problems due to unhealthy eating, drinking in lifestyle may not be fatal but they can a hard time to the body they occur in. One such problem is constipation. A common remedy for constipation is an enema. Apart from constipation, enema provides relief from backaches, fatigue, and headaches. A cleansing enema stimulates the bowels to expel any impacted fecal matter quickly. A remedy helpful for many health problems always grows rapidly as a market. The factors driving the market growth include rising chronic diseases in an aging population with cancer and diabetes coupled with the increasing prevalence of gastrointestinal disorders and growing awareness about enema administration. Home care is advisable to be administered only after the advice of the clinician. Factors that can cause roadblocks to the growth of global enema bags market include the possibility of newer methods of enema treatment and environmental concerns raised from the bags that are made up of silicone, rubber, etc.

Enema is the process of injecting fluid into the bowel via the rectum. This method is used to get relief from various conditions such as constipation, fatigue, headaches, and backaches. It is a process that helps to push out the waste from the rectum. A cleansing enema stimulates the bowels to expel any impacted fecal matter quickly.

The Global Enema Bag Industry is expected to gain prominence over the forecast period (2018–2023). It is estimated that the global enema bags market is expected to register a CAGR of ~ 10.2 % during the forecast period of 2018–2023.

Enema can be administered at hospitals as well as in home. This technique is also preferred before performing bowel procedures such as radiography and colonoscopy. The most common gastrointestinal condition affecting people nowadays is constipation with the ever-rising prevalence across the globe. Furthermore, the use of enema based products for bowel cleansing is growing extensively.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1363

However, certain disrupting factors that might restrain the growth of enema bags include the possibility of newer methods of enema treatment. Moreover, there might be environmental issues as the bags are made up of silicone, rubber, etc.

Segmentation

The global enema bags market is segmented on the basis of the material type, product type, application, capacity, and end-user.

On the basis of material type, the market is classified into silicone, rubber, and others.

On the basis of administration type, the market is segmented into cleansing enema, carminative enema, retention enema, return-flow enema, and others. Cleansing enema is further segmented into large volume enema, small volume enema, and prepackaged disposable enema. Retention enema is further segmented into oil enema, sedative enema, nutrient enema, anesthetic enema, medicinal enema, and others.

The global enema bags market on the basis of product type is segmented into closed or bottle enema, Higginson enema, bulb enema, bag or fountain travel enema, and others.

On the basis of indication, the market is segmented into constipation, diarrhea, obesity, cancer, and others.

On the basis of preparation, the market is divided into sodium phosphate enemas, coffee enemas, barium enemas, water-soluble contrast enemas, and others. Barium enemas are further segmented into single-column barium enema and double-contrast barium enema.

On the basis of application, the market is segmented as bowel clearing, contrast x-ray, medication administration, and others.

On the basis of capacity, the market is segmented into 100 to 250 ml, 250 to 400 ml, 400 to 600 ml, and others.

On the basis of end-user, the global enema bags market is segmented into hospitals, clinics, research centers, and others.

Geographically, the market has been segmented into America, Europe, Asia Pacific, and the Middle East and Africa. The American enema bags market is further segmented into North America and South America. North America is further classified as the U.S. and Canada.

The European enema bags market is segmented into Western Europe and Eastern Europe. Western Europe is further classified as Germany, France, the U.K., Italy, Spain, and the rest of Western Europe.

The Asia Pacific enema bags market is segmented into Japan, China, India, Republic of Korea, Australia, and the rest of Asia Pacific.

The Middle Eastern and African enema bags market is segmented into the Middle East and Africa.

Top Key Players

The key players in global enema bags market are Baxter International, Inc. (the USA), B Braun Melsungen AG (Germany), Cascade Healthcare Products, Inc. (the USA), Coloplast A/S (Denmark), Covidien Private Ltd. (Ireland), Farla Medical Ltd. (UK), Flexicare Medical Limited (UK), Hollister Incorporated (USA), MacoPharma (France), Medline Industries, Inc. (USA), Narang Medical Ltd. (India), Ocean Health Products Ltd. (Singapore), and Qingdao Sinoland International Trade Co., Ltd. (China).

Regional Market Summary

Globally, the American region is the largest market for enema bags owing to the high level of hygiene developed in hospitals and clinics, increasing use of enema-based products at home, and rising demand for enema kits by healthcare providers. As per a study conducted by the Canadian Journal of Gastroenterology, constipation is a common problem among the people in the North American region. Moreover, the study stated that 20% of the North American population suffers from constipation.

Asia Pacific and North America are expected to collectively dominate the enema bags market in terms of volume and value, respectively, due to the increase in awareness towards abdominal diseases and high demand from the pharmaceutical and healthcare industry. The U.S. has the largest market of enema bags in the North American region and countries such as India and China are the highest producers of enema bags in the Asia Pacific region. The factor influencing the growth is the increasing prevalence of chronic diseases such as obesity and diabetes. Currently, the major problem in China and India is diabetes. India had the world’s second-largest population of diabetic patients that was around 69.2 million in 2015 which is expected to increase to 123.5 million by 2040. The number of undiagnosed diabetes is higher in India which was around 36 million in 2015.

The European market is growing due to the increasing prevalence of diarrhea, obesity, and constipation. Increasing cases of enema administration procedures in hospitals are contributing to the progress of the market. The prevalence of diabetes is also found to be increasing in Europe. As per a study published by the World Health Organization, almost 60 million people in the European region have diabetes, and the prevalence tends to be high among people aging 30 years and above.

The Middle East and Africa also shows a steady rise in the market owing to the availability of enema-based products, lack of physical exercise, and increasing cases of constipation.

Access More Details of the Report @ https://www.marketresearchfuture.com/reports/enema-bag-market-1363

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Cardiovascular Needle Market Overview With Detailed Analysis, Competitive Landscape, Forecast To 2023

Cardiovascular Needle Market Information: By Type (Round-Bodied Needles, Cutting Needles), By Application (Open Heart Surgery, Cardiac Valve Procedures), By Usage (Single Use, Multiple Uses), By End User (Hospitals, Clinics) - Global Forecast till 2023

Market Insights:

According to the International Diabetes Federation in 2016, it was estimated that 420 million adult population had diabetes, which is increasing at the rate of 8.4% and is expected to reach 625 million by 2040. Furthermore, increasing prevalence of population suffering from cardiovascular diseases, diabetes, and obesity driving the growth of the cardiovascular needles market globally.

The global cardiovascular needles market is growing rapidly owing to its application in various fields such as open heart surgery, cardiac valve procedures, coronary artery bypass graft surgery, heart transplant, and others.

According to the World Health Organization (WHO) in 2015, around 1.6 million deaths were directly caused by diabetes and in 2014, 8.5% of adults aged 18 years and older had diabetes. Thus, rising prevalence of chronic diseases is majorly driving the global cardiovascular market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1234

According to the World Health Organization (WHO), in 2015, around 17.7 million people died from cardiovascular diseases, which represents 31% of all global deaths. Of these deaths, around 7.4 million were due to coronary heart disease and 6.7 million were due to stroke.

Various factors are adding fuel to the growth of the global cardiovascular needle market, such as unhealthy diet, low physical activities, etc. According to a research, smoking increases the possibility of diabetes; more than 60% of the global population smokes, this has increased the risk of diabetes and contributed to the growth of the market.

Moreover, advancing technology in the medical devices is adding fuel to the growth of the market. Furthermore, increasing government support in the developing countries drive the market growth.

However, increasing use of surgical staples instead of needles and suture can deter the demand for cardiovascular needles.

The global cardiovascular needle market is expected to grow at a CAGR of 7.2% during the forecast period 2017-2023.

Key Players

Some of the key the players in the market are Becton, Dickinson, and Company (US), B. Braun Melsungen AG (Germany), Sheffield Ltd. (UK), CP Medical, Inc. (the US), Ethicon Inc. (US), KLS Martin Group (US), Sklar Surgical Instruments (US), Rumex International Corporation Ltd. (US), Scanlan International Inc. (US), Teleflex Incorporated (US), Medline Industries, Inc. (US), Surgins surgical Ltd. (UK), Surtex Instruments Ltd. (UK), Cardivon Surgical Inc. (China), Symmetry Surgical Inc. (US), Delacroix-Chevalier (France), Wexler Surgical (US), Quality Needles Pvt. Ltd. (India), FSSB surgical needles GmbH (Germany)

Segmentations

The global cardiovascular needle market is segmented on the basis of types, by application, by usage, and by the end user.

On the basis of the type, it is segmented into round bodied needles and cutting needles. Furthermore, round-bodied needles segmented into taper point needles and blunt point needles. Also, cutting needles segmented into conventional cutting needles and reverse cutting needles.

On the basis of the application, it is segmented into open heart surgery, cardiac valve procedures, coronary artery bypass graft surgery, heart transplant, and others.

On the basis of the usage, it is segmented into single use and multiple uses.

On the basis of the end user, it is segmented into hospitals, clinics, ambulatory surgical centers, and others.

Regional Analysis

The Americas dominate the global cardiovascular needle market owing to the rising prevalence of diabetes, obesity, and cardiovascular diseases. Furthermore increasing government support for research & development have fuelled the growth of the market in this region. According to the American Heart Association, in 2017, cardiovascular disease listed as the underlying cause of death which is likely to account for nearly 801,000 deaths in the US by the end of this year. It further estimated that about 2,200 Americans die of cardiovascular disease each day.

Europe holds the second position in the global cardiovascular needle market owing to the presence of major players. Although companies within this region are also involved in export to the developing countries which leads the market of Europe.

The Asia Pacific is the fastest growing Cardiovascular Needle market owing to the high presence of a patient with cardiovascular disease. Furthermore, the government of this region is looking forward to better the quality of needles, which increases the demand for cardiovascular needle market in this region.

On the other hand, in the Middle East and Africa hold the least market due to low research and development activities and poor healthcare infrastructure.

Access More Details of the Report @ https://www.marketresearchfuture.com/reports/cardiovascular-needle-market-1234